| 查看: 325 | 回复: 1 | ||
zclovegirl金虫 (小有名气)
|
[求助]
求助文献 Amylin-its physiological role in humans
|
| 求助文献 Amylin-its physiological role in humans |
回复此楼» 猜你喜欢
外科大查房_病例选录
已经有0人回复
-
胃癌手术学 诊疗规范与操作指南
已经有0人回复
-
影像医学与生物医学工程论文润色/翻译怎么收费?
已经有103人回复
-
内分泌疾病诊治进展与案例汇总
已经有0人回复
-
呼吸科医师处方手册
已经有0人回复
-
腹股沟疝外科学
已经有0人回复
-
腹腔镜手术并发症的预防和处理
已经有0人回复
-
肛肠外科手术学
已经有0人回复
-
临床思维指南—外科疾病误诊误治与防范_
已经有1人回复
-
消化系统CT诊断-CT快速入门丛书
已经有0人回复
whding9266
金虫 (正式写手)
- 应助: 19 (小学生)
- 金币: 653.6
- 红花: 1
- 帖子: 310
- 在线: 27.8小时
- 虫号: 2070727
- 注册: 2012-10-18
- 性别: MM
- 专业: 心脏结构与功能异常
【答案】应助回帖
|
Abstract Amylin is a polypeptide hormone composed of 37 aminoacids, that is produced in pancreatic beta-cells, and that was discovered in 1987. Releasing amylin into the circulation is increased postprandially, proportionally to the amount of digested food. Daily profile of amylin plasma levels corresponds to the profile of insulin. Normal plasma levels of amylin vary from 4 pmol/L (fasting) to 25 pmol/L (postprandially). Receptors for amylin are highly concentrated especially in the central nervous system--area postrema and nucleus accumbens. There is a 20% sequence homology between amylin, calcitonin and adrenomedullin and 44% homology with calcitonin gene--related peptide. Amylin contributes to the regulation of postprandial glycaemia by suppression of glucagon release and by regulation of gastric emptying. Deficit os amylin is typical for diabetes mellitus type 1 or for the late stage of diabetes type 2. Insulin resistance in obese patients is characterized by increased levels of both insulin and amylin. Amylin decreases food intake and participates in the regulation of body weight. Some biochemical forms of amylin cause proliferation of osteoblasts and inhibit bone resorption. Amylin modulates insulin sensitivity of skeletal muscle, contributes to the regulation of blood pressure and causes vasodilatation. 抱歉，搞不到全文。 |
2楼2012-10-22 06:36:20